In a prospective multicenter study of 55 patients1,
Renuvion demonstrated.

98.2%

TREATMENT SUCCESS

90.9%

SELF-REPORTED APPEARANCE IMPORVEMENT IN 3 MONTHS

In preclinical testing, Renuvion showed benefits over the nitrogen plasma system, both in maximum contraction and depth of thermal effect.4

193-269%

GREATER TISSUE / WRINKLE REDUCTION

54-71%

LESS DEPTH OF THERMAL EFFECT

Renuvion is a non-surgical option for reducing wrinkles and rhytides. But it’s not for everybody. This procedure is not recommended for patients with darker skin tones and requires recovery time. Your doctor will talk to you about your goals, your lifestyle, and whether Renuvion is the right option for you.
Your doctor will work with you to choose the right level of anesthesia so you’re comfortable during the procedure.
The healing process typically takes about two weeks, but for certain individuals it could last longer. As with all procedures, individual results may vary.
As your face heals, you should expect redness, peeling, and some swelling. Your doctor will share photos of other patients during their recovery and explain in detail how to take care of your skin while it heals. For full information on the risks of this procedure, please review below.
As Seen on People
As Seen on BOTCHED
As Seen on ABC
As Seen on Haute Beauty
As Seen on New Beauty
As Seen on The Doctors

The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to severe wrinkles and rhytides, limited to patients with Fitzpatrick skin types I, II, or III.

Warning: Application of more than one treatment pass in the perioral area, on the forehead, and along the jawline has been associated with hypertrophic scarring.

Risks associated with the use of the Renuvion Dermal System include but are not limited to hypertrophic scarring, milia/acne, telangiectasia (spider veins), skin discoloration/hypopigmentation, dormant infection reactivation, infection, bruising or bleeding. As with any procedure, individual results may vary. As with all energy devices there are inherent risks associated with its use, refer to the IFU for further information.

References:

  1. Holcomb JD, Kelly M, Hamilton TK, DeLozier JB 3rd. A prospective study evaluating the use of helium plasma for dermal resurfacing. Lasers Surg Med 2020;52:940-951. https://doi.org/10.1002/lsm.23257
  2. Cohen SR, Henssler C, Horton K, Broder KW, Moise-Broder PA. Clinical experience with the Fraxel SR laser: 202 treatments in 59 consecutive patients. Plast Reconstr Surg 2008 May;121(5):297e-304e. doi: 10.1097/PRS.0b013e31816c3b65. PMID: 18453942.
  3. Shauly O, Stone GL, Shin R, Stevens GW, Gould DJ. Evaluating facelift complications and the effectiveness of the SMASectomy technique: A single center’s 15-year experience. Aesthet Surg J Open Forum 2021 Aug 20;3(4):ojab030. doi: 10.1093/asjof/ojab030. PMID: 34617012; PMCID: PMC8489308.
  4. Holcomb JD, Schucker A. Helium plasma skin regeneration: Evaluation of skin tissue effects in a porcine model and comparison to nitrogen plasma skin regeneration. Lasers Surg Med 2020;52:23-32. https://doi.org/10.1002/lsm.23167
back to top